AdAlta
AdAlta - Discovering and Developing Protein Based Therepeutics.
Launch date
Employees
Market cap
CAD10.2m
Enterprise valuation
CAD10m (Public information from Sep 2024)
Share price
AUD0.019 1AD.AX
Company register number 120332925
Melbourne Victoria (HQ & founding location)
Financials
Estimates*
AUD | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Revenues | - | - | <1m | <1m | <1m | 3.2m | - |
% growth | - | - | - | 38 % | 16 % | 224 % | - |
EBITDA | - | - | (5.8m) | (5.5m) | (5.9m) | (4.7m) | - |
% EBITDA margin | - | - | (950 %) | (649 %) | (599 %) | (147 %) | - |
Profit | - | - | (6.0m) | (5.6m) | (6.1m) | (4.9m) | - |
% profit margin | - | - | (975 %) | (664 %) | (614 %) | (152 %) | - |
EV / revenue | - | - | 20.7x | 31.3x | 12.5x | 2.5x | - |
EV / EBITDA | - | - | -2.2x | -4.8x | -2.1x | -1.7x | - |
R&D budget | - | - | - | 6.2m | 4.1m | 3.6m | - |
R&D % of revenue | - | - | - | 735 % | 418 % | 114 % | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$3.0m | Series A | ||
AUD50.0k | Grant | ||
N/A | N/A | IPO | |
AUD1.0m | Grant | ||
N/A | AUD8.1m | Private Placement VC | |
* | N/A | AUD1.9m | Post IPO Equity |
Total Funding | CAD12.2m |
Related Content
Recent News about AdAlta
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.